ACR 3518

Status Date:  October 20, 2022  | Status:  Open to Accrual

ACR 3518

Phase I Safety Assessment of Hypofractionated Postoperative Radiotherapy (H-PORT) for Intermediate-Risk Head and Neck Cancer

Principal Investigator

Etta Pisano, MD

Primary Objective

To determine if a hypofractionated postoperative radiotherapy (H-PORT) schedule for patients with intermediate-risk head and neck cancer (squamous cell carcinoma of the oral cavity, oropharynx, or larynx) who have undergone surgery is safe and feasible for further evaluation in a phase II clinical trial

Patient Population

Head and Neck; Patients with intermediate-risk head and neck cancer (squamous cell carcinoma of the oral cavity, oropharynx, or larynx)

Study Information

This trial is sponsored by the American College of Radiology in collaboration with RTOG Foundation and funded by the Pennsylvania Department of Health Commonwealth Universal Research Enhancement Program (PA CURE). The trial is open to institutions in Pennsylvania.

Participating Sites

Institution Name City State/Country
Jefferson University Hospitals Philadelphia PA
Pennsylvania State University Hershey PA
University of Pittsburgh Medical Center Pittsburgh PA

Participate in RTOG Research

To participate as an RTOG study investigator, your organization must be part of the RTOG Foundation network. Patients who wish to participate in a study must be under the care of an RTOG participating investigator. For additional information, email info@rtog.org or call 1-215-574-3173.

See our clinical trials